Advanced Drug Delivery Systems in Management of Chronic Obstructive Pulmonary Disease
- Publisher's listprice GBP 125.00
-
61 687 Ft (58 750 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 6 169 Ft off)
- Discounted price 55 519 Ft (52 875 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
61 687 Ft
Availability
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number 1
- Publisher CRC Press
- Date of Publication 24 June 2025
- ISBN 9781032812595
- Binding Hardback
- No. of pages286 pages
- Size 254x178 mm
- Weight 690 g
- Language English
- Illustrations 2 Illustrations, black & white; 16 Illustrations, color; 2 Line drawings, black & white; 16 Line drawings, color; 17 Tables, black & white 681
Categories
Short description:
This book reviews the epidemiology, etiology, ongoing clinical trials, emerging personalized therapies, advanced drug delivery systems, and pathophysiology of Chronic Obstructive Pulmonary Disease (COPD). It serves as a valuable resource for professionals, scientists, academicians, and clinicians specializing in respiratory health.
MoreLong description:
This book offers a comprehensive overview of the epidemiology, etiology, and pathophysiology of chronic obstructive pulmonary disease (COPD). It addresses the limitations of existing drug delivery methods and explores advanced delivery systems to overcome these challenges, providing an exhaustive account of their intricate mechanisms. The introductory chapters elucidate pathways responsible for COPD progression, followed by a detailed analysis of established biomarkers and potential targets in contemporary COPD therapy. Subsequent chapters provide insights into ongoing treatment modalities, their efficacy, drawbacks, and prospective solutions to counter the setbacks of COPD therapy. The subsequent section covers state-of-the-art drug delivery technologies and novel drug formulations designed to enhance drug deposition and absorption in COPD lungs. It further explores a methodical yet coordinated explanation of targeted personalized therapies and emerging approaches, including nanoparticles, polymeric carriers, and vesicular delivery systems. Toward the end, the book discusses ongoing and completed clinical trials encompassing the management of COPD through advanced drug delivery approaches. It serves as a valuable resource for professionals, scientists, academicians, and clinicians specializing in respiratory health.
- Provides an in-depth understanding of the epidemiology, etiology, and pathophysiology of Chronic Obstructive Pulmonary Disease (COPD)
- Delve into pathways responsible for COPD progression, conducting a detailed analysis of established biomarkers and potential targets in contemporary COPD therapy
- Offer insights into ongoing treatment modalities, evaluating their efficacy, drawbacks, and proposing prospective solutions to counter the setbacks of COPD therapy
- Systematically organizes information on state-of-the-art drug delivery technologies and novel formulations designed to enhance drug deposition and absorption in COPD lungs
- Presents a methodical explanation of targeted personalized therapies and emerging approaches, including nanoparticles, polymeric carriers, and vesicular delivery systems
Table of Contents:
Chapter 1: Introduction to COPD: Epidemiology, Etiology, and Pathophysiology
Chapter 2: Biomarkers for the Management of Chronic Obstructive Pulmonary Disease
Chapter 3: Current Treatment Modalities for Chronic Obstructive Pulmonary Disease: Challenges and Limitations
Chapter 4: Inhaled Drug Delivery Systems in the Management of Chronic Obstructive Pulmonary Disease
Chapter 5: Advancements in Smart Inhaler Technology for Enhancing Chronic Obstructive Pulmonary Disease Care
Chapter 6: Nanotechnology in Pulmonary Drug Delivery
Chapter 7: Liposomal Drug Delivery in the Management of Chronic Obstructive Pulmonary Disease
Chapter 8: Polymeric Nanoparticles for Targeted Therapy of Chronic Obstructive Pulmonary Disease
Chapter 9: Hybrid Nanocarriers for the Delivery of Therapeutics in Chronic Obstructive Pulmonary Disease
Chapter 10: Dendrimers as Emerging Drug Carriers in Chronic Obstructive Pulmonary Disease
Chapter 11: Biodegradable Polymers for Controlled Release of Drugs in Chronic Obstructive Pulmonary Disease
Chapter 12: Nano-Approaches for the Delivery of Biologics in Chronic Obstructive Pulmonary Disease
Chapter 13: Nano Theranostics for Chronic Obstructive Pulmonary Disease: Status and Implications
Chapter 14: Senolytics: A Potential Therapeutic Approach for COPD Management
Chapter 15: Precision Care: Personalized Medicine in Chronic Obstructive Pulmonary Disease Management
Chapter 16: Digital Health Solutions: Enhancing Medication Adherence in COPD Treatment
Chapter 17: Clinical Trials and Regulatory Issues of Nanocarriers Employed in the Treatment of Chronic Obstructive Pulmonary Disease
Chapter 18: Prospects of Advanced Drug Delivery Systems in Combating Chronic Obstructive Pulmonary Disease
